ATE424808T1 - Pharmazeutische zusammensetzungen mit corticosteroiden und antiinfektiva - Google Patents

Pharmazeutische zusammensetzungen mit corticosteroiden und antiinfektiva

Info

Publication number
ATE424808T1
ATE424808T1 AT01996371T AT01996371T ATE424808T1 AT E424808 T1 ATE424808 T1 AT E424808T1 AT 01996371 T AT01996371 T AT 01996371T AT 01996371 T AT01996371 T AT 01996371T AT E424808 T1 ATE424808 T1 AT E424808T1
Authority
AT
Austria
Prior art keywords
pharmaceutically acceptable
infectives
pharmaceutical compositions
compositions containing
agent
Prior art date
Application number
AT01996371T
Other languages
English (en)
Inventor
Mohan Chandavarkar
Nandan Chandavarkar
Mainde Chandrashekhar
Original Assignee
Chandavarkar Mohan A
Chandavarkar Nandan M
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chandavarkar Mohan A, Chandavarkar Nandan M filed Critical Chandavarkar Mohan A
Application granted granted Critical
Publication of ATE424808T1 publication Critical patent/ATE424808T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT01996371T 2000-11-15 2001-11-12 Pharmazeutische zusammensetzungen mit corticosteroiden und antiinfektiva ATE424808T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1018MU2000 2000-11-15
IN1077MU2001 2001-11-09

Publications (1)

Publication Number Publication Date
ATE424808T1 true ATE424808T1 (de) 2009-03-15

Family

ID=26324912

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01996371T ATE424808T1 (de) 2000-11-15 2001-11-12 Pharmazeutische zusammensetzungen mit corticosteroiden und antiinfektiva

Country Status (9)

Country Link
US (2) US20040077562A1 (de)
EP (1) EP1337237B1 (de)
AT (1) ATE424808T1 (de)
AU (2) AU2002216357B2 (de)
BR (1) BR0115415A (de)
CA (1) CA2428189A1 (de)
DE (1) DE60137960D1 (de)
MX (1) MXPA03004241A (de)
WO (1) WO2002039993A2 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004069280A1 (en) * 2003-02-06 2004-08-19 Cipla Ltd Pharmaceutical inclusion complexes containing a steroid and optionally an antibacterial agent
EP1596823A2 (de) * 2003-02-21 2005-11-23 Sun Pharmaceuticals Industries Ltd. Stabile ophthalmische zusammensetzung
EP1627637A1 (de) * 2003-05-23 2006-02-22 Santen Pharmaceutical Co., Ltd. Ophthalmische lösung mit antimikrobieller chinolon-verbindung
US20050101582A1 (en) 2003-11-12 2005-05-12 Allergan, Inc. Compositions and methods for treating a posterior segment of an eye
US20070224278A1 (en) * 2003-11-12 2007-09-27 Lyons Robert T Low immunogenicity corticosteroid compositions
US20060141049A1 (en) * 2003-11-12 2006-06-29 Allergan, Inc. Triamcinolone compositions for intravitreal administration to treat ocular conditions
US20070020299A1 (en) 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
DE602005011928D1 (de) 2004-01-20 2009-02-05 Allergan Inc Zusammensetzungen für die lokalisierte therapie des auges, vorzugsweise enthaltend triamcinolon-acetonid und hyaluronsäure
DE602005026225D1 (de) * 2004-03-12 2011-03-24 Cipla Ltd Sterilisationsprozess für Steroide
US8119154B2 (en) 2004-04-30 2012-02-21 Allergan, Inc. Sustained release intraocular implants and related methods
US8147865B2 (en) 2004-04-30 2012-04-03 Allergan, Inc. Steroid-containing sustained release intraocular implants and related methods
US8748402B2 (en) 2004-06-07 2014-06-10 Bausch & Lomb Pharma Holdings Corp. Ophthalmic formulations and uses thereof
US8372814B2 (en) 2004-06-07 2013-02-12 Ista Pharmaceuticals, Inc. Ophthalmic formulations and uses thereof
EP1761265A2 (de) * 2004-06-28 2007-03-14 ALZA Corporation Arzneimittel/polymer-komplex, vorzugsweise ciprofloxacin/hpmc, sein herstellungsverfahren mit lyophilisation und seine verwendung in einer osmotischen vorrichtung
WO2006017347A2 (en) * 2004-07-12 2006-02-16 Allergan, Inc. Opthalmic compositions and methods for treating ophthalmic conditions
WO2006043965A1 (en) * 2004-10-14 2006-04-27 Allergan, Inc. Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods
US8668676B2 (en) * 2006-06-19 2014-03-11 Allergan, Inc. Apparatus and methods for implanting particulate ocular implants
WO2008002117A1 (es) * 2006-06-27 2008-01-03 Jimenez Bayardo, Arturo Solución oftálmica de ciprofloxacina y dexametasona
US9039761B2 (en) 2006-08-04 2015-05-26 Allergan, Inc. Ocular implant delivery assemblies with distal caps
EP2121027A2 (de) * 2007-01-17 2009-11-25 Devirex AG Cyclodextrinformulierungen
WO2008130211A1 (es) * 2007-04-20 2008-10-30 Serral, S.A. De C.V. Solución dinámica, estequiométrica de soporte y de equilibrio inducido
US12370352B2 (en) 2007-06-28 2025-07-29 Cydex Pharmaceuticals, Inc. Nasal and ophthalmic delivery of aqueous corticosteroid solutions
US8545554B2 (en) * 2009-01-16 2013-10-01 Allergan, Inc. Intraocular injector
PL3548091T3 (pl) * 2016-11-29 2022-03-28 Oculis SA Otrzymywanie stałych kompleksów cyklodekstryny do dostarczenia czynnego składnika farmaceutycznego do oczu
DK3993807T3 (da) 2019-07-01 2026-01-19 Oculis Operations Sarl Fremgangsmåde til stabilisering af ph-værden i en vandig sammensætning, der indeholder et lægemiddel
US20230233572A1 (en) 2020-06-11 2023-07-27 Sentiss Pharma Private Limited Ophthalmic compositions comprising a combination of fluoroquinolone antibacterial agent and an anti-inflammatory agent

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990001933A1 (en) * 1988-08-26 1990-03-08 Alcon Laboratories, Inc. Combination of quinolone antibiotics and steroids for topical ophthalmic use
US5374432A (en) * 1989-07-28 1994-12-20 The Trustees Of Columbia University Of The City Of New York Topical anti-infective ointment containing silver or silver salts and antibiotics
US5318780A (en) * 1991-10-30 1994-06-07 Mediventures Inc. Medical uses of in situ formed gels
US5472954A (en) * 1992-07-14 1995-12-05 Cyclops H.F. Cyclodextrin complexation
US5540930A (en) * 1993-10-25 1996-07-30 Pharmos Corporation Suspension of loteprednol etabonate for ear, eye, or nose treatment
US5516808A (en) * 1994-10-27 1996-05-14 Sawaya; Assad S. Topical cellulose pharmaceutical formulation
JP2003510263A (ja) * 1999-09-24 2003-03-18 アルコン，インコーポレイテッド シプロフロキサシンおよびデキサメタゾンを含有する局所用懸濁処方物
US6824804B2 (en) * 2001-09-27 2004-11-30 Broyles Properties, Ltd. Pecan processing method and system

Also Published As

Publication number Publication date
US20070248565A1 (en) 2007-10-25
WO2002039993A2 (en) 2002-05-23
DE60137960D1 (de) 2009-04-23
AU2002216357B2 (en) 2006-08-17
US20040077562A1 (en) 2004-04-22
EP1337237B1 (de) 2009-03-11
BR0115415A (pt) 2003-09-09
WO2002039993A3 (en) 2003-02-27
CA2428189A1 (en) 2002-05-23
MXPA03004241A (es) 2004-12-03
AU1635702A (en) 2002-05-27
EP1337237A2 (de) 2003-08-27

Similar Documents

Publication Publication Date Title
ATE424808T1 (de) Pharmazeutische zusammensetzungen mit corticosteroiden und antiinfektiva
CY1112499T1 (el) Φαρμακευτικες συνθεσεις ενος νευροδραστικου στεροειδους και χρησεις αυτων
AU2002243387A1 (en) Pharmaceutical dosage form for oral administration of low molecular weight heparin
CY1120313T1 (el) Φαρμακευτικη συνθεση για δερματικη χρηση για να θεραπευεται ψωριαση που περιλαμβανει βιταμινη d και κορτικοστεοειδες
ATE235895T1 (de) Arzneistoff-abgabesystem enthaltend eine festgepackte, feste arzneistoffbasis
NO20032511D0 (no) Farmasöytiske sammensetninger for oral tilförsel av farmakologisk aktive midler
CY1115289T1 (el) Μεθοδοι αγωγης εναντι ασθενειας που σχετιζεται με φλεγμονη
PT1289576E (pt) Combinacoes de medicamentos uteis para a prevencao da restenose
CO5560580A2 (es) Formulaciones de sucralosa para disumular sabores desagradables
TR200102226T2 (tr) Formoterol ve bir tiotropium tuzunun kombinasyonları
DK0991407T4 (da) Stabilisering af syresensitive benzimidazoler med amino/cyclodextrin-kombinationer
BRPI0015567B8 (pt) composto, composição farmacêutica, forma de unidade de dosagem, uso da composição farmacêutica e método para preparar uma composição farmacêutica
CY1105953T1 (el) Συνθεσεις για απελευθερωση συνδυασμων φαρμακων
WO2002013873A3 (en) P97-active agent conjugates and their methods of use
CY1111698T1 (el) Συνδυασμος που περιλαμβανει εναν ανταγωνιστη υποδοχεα ατ1 και εναν ενισχυτη εκκρισης ινσουλινης ή εναν ευαισθητοποιητη ινσουλινης
CY1105065T1 (el) Φαρμακευτικα μεσα βασιζομενα σε γεσταγονα για δepματικη χρηση
DK1073467T3 (da) Formuleringer med co-oplösningsmiddel omfattende en forbindelse af vitamin D
LT2001119A (en) Pharmaceutical formulations comprising intranasal morphine and use thereof
TR199900336T2 (xx) EAA antagonistleri olarak tetrahidrokinolin t�revleri.
ATE359777T1 (de) Fenofibratsäure enthaltende pharmazeutische zusammensetzung und deren physiologisch verträgliche salze und derivate
ATE386725T1 (de) Heterocyclylverbindungen
ATE357928T1 (de) Pharmazeutische zusammensetzung für thrombinpeptidderivaten
CA2352915A1 (en) Pharmaceutical compositions containing mupirocin
SI1526856T1 (sl) Farmacevtski sestavek, ki obsega estetrolne derivate za uporabo pri zdravljenju raka
CY1105795T1 (el) Σκευασματα για βελτιωση της βιοδιαθεσιμοτητας χορηγουμενων απο το στομα φαρμακων

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties